Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Stephen Saxe (NPI 1699750844)

Field	Value
Entity Type	Individual
Organization	Stephen Saxe
Address	11220 Illinois St Ste 110
City	Carmel
State	IN
ZIP	46032
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	December 9, 2005

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider’s revenue mix is concentrated in intravitreal pharmacologic therapy and retinal procedure codes, consistent with a retina specialist practice: J0178 shows 1.7K claims, $689 avg paid/claim, $1.2M revenue (62.8% of Medicare revenue), J2777 shows 12.5K claims, $29 avg paid/claim, $363.7K revenue (19.5%), and 67028 shows 1.4K claims, $98 avg paid/claim, $141.4K revenue (7.6%). The top three codes together account for 89.9% of the provider’s Medicare revenue, indicating operations are heavily focused on intravitreal injections plus associated retina-focused procedures and follow-up visits.

Revenue concentration is extreme around a small set of drug and injection codes: the precomputed top-3 share is 89.9% of Medicare revenue, with J0178 alone representing $1.2M of the $1.9M total Medicare revenue. This degree of concentration implies the practice’s financial performance on Medicare is highly dependent on anti-VEGF and related intravitreal therapies.

Payer mix is effectively single‑payer Medicare: lifetime Medicare revenue is $1.9M while Medicaid shows none on file. With no Medicaid billing reported, the provider’s public-payer exposure is concentrated entirely in Medicare, which has implications for contracting and referral strategies that assume Medicare-dominant volumes.

On competitive standing for the top revenue drivers the provider is a solid but not dominant national participant: J0178 ranks #689 of 3204 providers nationally (79th percentile; typical, unremarkable volume), J2777 ranks #842 of 2039 (59th percentile; typical, unremarkable volume), and 67028 ranks #851 of 4255 (80th percentile; typical, unremarkable volume). These percentiles indicate above-average engagement in these services relative to many peers but do not reflect national dominance in volume for those codes.

There are notable statistical outliers in the provider’s Medicare mix: J3590 (unclassified biologics) is billed 699 times for $48.2K and is described as 94th percentile (notably above typical national volume), and 92134 (computerized retinal imaging) has 1.6K claims for $47.3K and is in the 95th percentile (notably above typical national volume). These elevated percentiles suggest the practice uses OCT/imaging and some unclassified biologic billing more frequently than most peers, which may reflect specific clinical preferences or case mix.

Diagnostic and ancillary retinal testing comprises a meaningful though smaller share of revenue: 92134 accounts for $47.3K (2.5% of Medicare revenue) and 92235 fluorescein angiography accounts for $17.3K (0.9%). High claim counts for imaging paired with the 95th-percentile rank for 92134 point to a workflow that integrates frequent retinal imaging alongside injection-based treatment.

Surgical retina and more resource‑intensive procedures appear to be a minor component of revenue: 67042 (vitreous removal with ILM peeling) shows 17 claims and $14.5K (0.8% of Medicare revenue) and 67039 shows 11 claims and $7.9K (0.4%). This pattern reinforces that the practice’s primary service line is medical retina/intravitreal injection management rather than high-volume vitreoretinal surgery.

Provider tenure is long-standing: the NPI was enumerated on 2005-12-09 (~21 years ago), indicating an established clinical presence. Combined with the concentrated injection-focused revenue profile, the long tenure suggests sustained specialization in retina services over time rather than a recent shift in practice focus.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,700	$690	$1.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	12,540	$30	$363.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,440	$100	$141.4K
J3590	Unclassified biologics	700	$70	$48.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,630	$30	$47.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	450	$60	$27.7K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	180	$100	$17.3K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$860	$14.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	90	$120	$10K
67039	The provider removes vitreous humor from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana. This procedure also includes the…	10	$720	$7.9K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Indiana Distribution

Stephen Saxe — 1 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	15	60	830	$690	$868.8K
J2777	13	40	6,750	$30	$395.6K
67028	21	80	550	$80	$78.6K
67042	8	20	20	$1,310	$47K
67039	5	10	20	$1,280	$34.5K
J3590	11	50	220	$60	$24.5K
J9035	30	30	200	$50	$19.2K
92235	10	40	90	$100	$15.8K
99214	7,287	10,540	110	$80	$15.5K
99213	657	10,820	80	$50	$7.6K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Stephen Saxe, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ankur Shah	IN	Retina Specialist (Ophthalmology) Physician	$1.6M	$1.4M
Raj Maturi	IN	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Paul Sanchez	NM	Ophthalmology Physician	$348.6K	$0
Kenneth Downes	NM	Ophthalmology Physician	$310K	$0
Kurt Andreason	OR	Ophthalmology Physician	$305.6K	$0
Denis Jusufbegovic	IN	Retina Specialist (Ophthalmology) Physician	$210.6K	$0
Thomas Gillette	NM	Ophthalmology Physician	$90.2K	$0
Katia Chavez	NM	Ophthalmology Physician	$50.2K	$0

Nearby Providers

Other providers in the same ZIP code as Stephen Saxe, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Aspire Indiana Inc.	IN	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$26.2M
Landmark Recovery Of Carmel LLC	IN	Substance Abuse Rehabilitation Facility	$0	$26.2M
Little Star Center, Inc.	IN	Early Intervention Provider Agency	$0	$22.7M
Arrow Consultation Services, Inc.	IN	Developmentally Disabled Services Day Training Agency	$0	$10.5M
Indiana University Health North Hospital Inc	IN	General Acute Care Hospital	$0	$6.9M
Option Care Enterprises, Inc.	IN	Home Infusion Therapy Pharmacy	$0	$5.2M
Impact Physician Group, Indiana LLC	IN	Internal Medicine Physician	$0	$4.2M
Westmed, LLC	IN	Durable Medical Equipment & Medical Supplies	$0	$4M
Chinthala, PC	IN	Psychiatry Physician	$0	$3.9M
American Health Network Of Indiana, LLC	IN	Clinical Medical Laboratory	$2.2M	$1.6M

Stephen Saxe — Billing Profile & Reimbursement Data

Sign up for Stephen Saxe — Billing Profile & Reimbursement Data policy alerts

Stephen Saxe — Billing Profile & Reimbursement Data

Sign up for Stephen Saxe — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References